Consensus Enovis Corporation

Stocks

ENOV

US1940145022

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 16:00:03 2026-09-02 EDT			5-day change	1st Jan Change
20.20 ^USD	-1.61%		-20.00%	-24.17%

09-01	Top Midday Decliners	MT
09-01	BMO Capital Adjusts Enovis Price Target to $27 From $30, Maintains Outperform Rating	MT

Evolution of the Average Target: Enovis Corporation

Evolution of the Target Price: Enovis Corporation

Changes in Analyst Recommendations: Enovis Corporation

20deed1d318a03a6ce5c48792d.-WiYgG0B5uGlsL54jL40M9myJIYmdFOoQRz_miOnklg.th7P2Sxtk7Li_sk25d1sdZjkXc0QLBzJC0yw72WT4g6jWtb2OHSU1vz5yQ~d1dc09d9ea27d89be2d4ea489ef3990d

Analysts' recommendations: Enovis Corporation

09-01	BMO Capital Adjusts Enovis Price Target to $27 From $30, Maintains Outperform Rating	MT
07-28	UBS Adjusts Price Target on Enovis to $51 From $50, Maintains Buy Rating	MT
07-09	BMO Capital Initiates Enovis at Outperform With $29 Price Target	MT
02-27	Needham Raises Price Target on Enovis to $52 From $49, Keeps Buy Rating	MT
01-06	BTIG Initiates Enovis at Buy With $41 Price Target	MT
25-08-08	Needham Cuts Price Target on Enovis to $49 From $57, Keeps Buy Rating	MT
25-08-08	UBS Adjusts Enovis Price Target to $57 From $65, Maintains Buy Rating	MT
25-05-12	UBS Adjusts Price Target on Enovis to $65 From $75, Maintains Buy Rating	MT
24-10-03	JMP Securities Initiates Enovis at Outperform With $62 Price Target	MT
24-08-08	Needham Adjusts Price Target on Enovis to $65 From $82, Maintains Buy Rating	MT
24-06-13	JPMorgan Initiates Enovis at Neutral With $53 Price Target	MT
24-02-23	Canaccord Genuity Ups Price Target on Enovis to $75 From $73, Maintains Buy Rating	MT
24-02-23	Needham Raises Price Target on Enovis to $82 From $73, Maintains Buy Rating	MT
24-02-13	Stephens Initiates Enovis With Overweight Rating, $72 Price Target	MT
24-01-22	UBS Initiates Coverage on Enovis With Buy Rating, $75 Price Target	MT
24-01-03	William Blair Initiates Enovis at Outperform Rating	MT
23-12-20	Canaccord Genuity Adjusts Enovis Price Target to $71 From $65, Maintains Buy Rating	MT
23-12-15	Needham Adjusts Price Target on Enovis to $70 From $62, Keeps Buy Rating	MT
23-08-04	Baird Adjusts Price Target on Enovis to $70 From $67, Maintains Outperform Rating	MT
23-06-26	Needham Initiates Enovis With Buy Rating, $70 Price Target	MT
23-05-12	Wells Fargo Upgrades Enovis to Overweight Rating From Equal Weight, Adjusts Price Target to $67 From $55	MT
23-02-24	Baird Adjusts Enovis Price Target to $64 From $68, Maintains Outperform Rating	MT
22-11-03	Baird Adjusts Enovis' Price Target to $68 From $73, Keeps Outperform Rating	MT
22-10-26	Wells Fargo Lowers Enovis' Price Target to $53 From $60, Keeps Equalweight Rating	MT
22-10-12	Jefferies Initiates Enovis at Buy with $60 Price Target	MT

More recommendations

Medical Devices & Implants

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
ENOVIS CORPORATION			+91.59%
STRYKER CORPORATION			+20.58%
SMITH & NEPHEW PLC			+19.94%
GLAUKOS CORPORATION			+11.58%
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.			+42.15%
DOUBLE MEDICAL TECHNOLOGY INC.	-	-	+25.51%
INSPIRE MEDICAL SYSTEMS, INC.			-1.82%
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.			+43.24%
Average			+31.60%
Weighted average by Cap.			+21.11%